Comparison between Capital Infra Trust InvIT and Senores Pharmaceuticals IPO.
Capital Infra Trust InvIT is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Senores Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Capital Infra Trust InvIT is up to ₹1,578.00 Cr whereas the issue size of the Senores Pharmaceuticals IPO is up to ₹582.11 Cr. The final issue price of Capital Infra Trust InvIT is ₹99.00 per share and of Senores Pharmaceuticals IPO is ₹391.00 per share.
| Capital Infra Trust InvIT | Senores Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹99 per share | ₹10 per share |
| Issue Price (Lower) | ₹99.00 per share | ₹372.00 per share |
| Issue Price (Upper) | ₹100.00 per share | ₹391.00 per share |
| Issue Price (Final) | ₹99.00 per share | ₹391.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 150 shares | 38 shares |
| Fresh Issue Size | 10,87,87,800 shares | 1,27,87,723 shares |
| Fresh Issue Size (Amount) | up to ₹1,077.00 Cr | up to ₹500.00 Cr |
| OFS Issue Size | 5,06,05,950 shares | 21,00,000 shares |
| OFS Issue Size (Amount) | up to ₹501.00 Cr | up to ₹82.11 Cr |
| Issue Size Total | 15,93,93,750 shares | 1,48,87,723 shares |
| Issue Size Total (Amount) | up to ₹1,578.00 Cr | up to ₹582.11 Cr |
Capital Infra Trust InvIT opens on Jan 07, 2025, while Senores Pharmaceuticals IPO opens on Dec 20, 2024. The closing date of Capital Infra Trust InvIT and Senores Pharmaceuticals IPO is Jan 09, 2025, and Dec 24, 2024, respectively.
| Capital Infra Trust InvIT | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Jan 06, 2025 | Dec 19, 2024 |
| Issue Open | Jan 07, 2025 | Dec 20, 2024 |
| Issue Close | Jan 09, 2025 | Dec 24, 2024 |
| Basis Of Allotment (Tentative) | Jan 14, 2025 | Dec 26, 2024 |
| Initiation of Refunds (Tentative) | Jan 16, 2025 | Dec 27, 2024 |
| Credit of Share (Tentative) | Jan 16, 2025 | Dec 27, 2024 |
| Listing date (Tentative) | Jan 17, 2025 | Dec 30, 2024 |
| Anchor Lockin End date 1 | Feb 12, 2025 | Jan 24, 2025 |
| Anchor Lockin End date 2 | Apr 13, 2025 | Mar 25, 2025 |
Capital Infra Trust InvIT P/E ratio is , as compared to Senores Pharmaceuticals IPO P/E ratio of 39.77.
| Capital Infra Trust InvIT | Senores Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 66.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 45.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 39.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1350.70 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.73% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Capital Infra Trust InvIT Retail Individual Investors (RII) are offered 0 shares while in Senores Pharmaceuticals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 4,85,35,200 shares in Capital Infra Trust InvIT and 44,43,818 shares in Senores Pharmaceuticals IPO.
| Capital Infra Trust InvIT | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,10,10,000 shares | 66,65,725 shares |
| Market Maker Reservation | 0 shares | |
| QIB | 4,85,35,200 shares | 44,43,818 shares |
| NII | 3,98,48,550 shares | 22,21,908 shares |
| RII | 0 shares | 14,81,272 shares |
| Employee | 0 shares | 75,000 shares |
| Others | ||
| Total | 15,93,93,750 shares | 1,48,87,723 shares |
Capital Infra Trust InvIT subscribed 2.80x in total, whereas Senores Pharmaceuticals IPO subscribed 97.86x.
| Capital Infra Trust InvIT | Senores Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 0.93x | 97.84x |
| NII (times) | 100.35x | |
| Big NII (times) | 95.25x | |
| Small NII (times) | 111.35x | |
| RII (times) | 93.16x | |
| Employee (times) | ||
| Other (times) | 5.08x | |
| Total (times) | 2.80x | 97.86x |
